AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1844999
Drug: Glucose polymer
RxNorm normalized name: glucose polymers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose polymer (GP: multidextrin in 7% solution with water)
Trial: 6097377
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg p.o.) in acute studies
Trial: 6097377
Drug: Enalapril titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril titrated from 5 mg to 20 mg twice a day in chronic studies
Trial: 27127325
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + AZM tablets
Trial: 27127325
Drug: AZM patch
RxNorm normalized name: Azmiro
DrugBank: Testosterone cypionate (DB13943)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AZM patch monotherapy
Trial: 27127325
Drug: AZM tablet
RxNorm normalized name: Azmiro
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AZM tablet as monotherapy
Trial: 27127325
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + AZM patch
Trial: 27127325
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + AZM tablet
Trial: 19161955
Drug: Sunflower Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflower Therapy
Trial: 17313701
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of pancreatic polypeptide (PP) at 5 pmol/kg per min
Trial: 17313701
Drug: PP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PP infusion
Trial: 15356657
Drug: Low-dose etoposide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose etoposide (50 mg/m² per day) administered orally as a single agent for 7 days
Trial: 15356657
Drug: Low-dose etoposide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose etoposide (50 mg/m² per day) administered orally
Trial: 11254520
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (n = 49) with a respiratory therapist‐driven weaning protocol including daily screens and spontaneous breathing trials (SBT) for 2 hours.
Trial: 1153148
Drug: DMPA (Depo-Provera,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMPA (Depo-Provera, Upjohn) 150 mg IM monthly
Trial: 1153148
Drug: Sterile saline
RxNorm normalized name: Aqua Care Sterile Saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile saline 1.5 ml IM monthly (Control)
Trial: 31837640
Drug: Zinc (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (30 mg/d)
Trial: 31837640
Drug: Zinc (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc (30 mg/d) + Vitamin D (2000 IU/d)
Trial: 28494777
Drug: Antimicrobial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial therapy plus oseltamivir
Trial: 28494777
Drug: Antimicrobial therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial therapy alone (control group)
Trial: 21226960
Drug: Self-help coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-help coping advice emails (twice weekly for six weeks)
Trial: 21226960
Drug: General information
RxNorm normalized name: INFORMATION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General information about depression emails (twice weekly for six weeks)
Trial: 18157642
Drug: Transurethral collagen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral collagen injection midurethrally
Trial: 18157642
Drug: Transurethral collagen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transurethral collagen injection at the bladder neck
Trial: 8785393
Drug: Long-term RHSD
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term RHSD therapy
Trial: 6666222
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg ISDN sr
Trial: 30659468
Drug: New standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New standard operating procedure (SOP) using a combination of esketamine and propofol
Trial: 28110894
Drug: High-risk patients
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-risk patients (hs-CRP ≥3.84mg/L and Lp-PLA2 >239μg/L)
Trial: 23283254
Drug: Topical ice
RxNorm normalized name: Camphor Ice Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ice pack
Trial: 11021442
Drug: Porous‐coated Miller‐Galante
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porous‐coated Miller‐Galante II (MG II) total knee arthroplasty
Trial: 9070551
Drug: Trandolapril 1
RxNorm normalized name: trandolapril 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 1 mg/day for 1 month and 2 mg/day for the following 2 months (n = 49)
Trial: 9070551
Drug: Trandolapril 1
RxNorm normalized name: trandolapril 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 1 mg/day for 1 month and 2 mg/day for the following 2 months plus Verapamil 240 mg/day for 1 month and 360 mg/day for 2 months (n = 51)
Trial: 12959317
Drug: Oxcarbazepine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (600 mg) in patients on phenobarbitone
Trial: 12959317
Drug: Oxcarbazepine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (600 mg) in patients on sodium valproate
Trial: 12959317
Drug: Oxcarbazepine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine (600 mg) in healthy control subjects
Trial: 31758920
Drug: Drospirenone (DRSP)
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Drospirenone (DRSP) 3 mg and Ethinyl Estradiol (EE) 0.02 mg
Trial: 24906459
Drug: Exercise dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise dose for general health (8 kcal/kg body weight per week, about 900 kcal/wk)
Trial: 24906459
Drug: Exercise dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise dose for weight loss (20 kcal/kg body weight per week, about 2,250 kcal/wk)
Trial: 23770788
Drug: Allopurinol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (10 mg/kg body weight, 3 times before operation)
Trial: 21364503
Drug: Lidocaine 40
RxNorm normalized name: lidocaine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 40 mg and Flurbiprofen axetil 50 mg (combination)
Trial: 18485028
Drug: Docetaxel 70
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 70 mg/m² on day 1 (arm A)
Trial: 18485028
Drug: Docetaxel 70
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 70 mg/m² on day 2 plus oral estramustine phosphate (EP) 840 mg total daily dose on days 1-5 (arm B)
Trial: 16455821
Drug: Intervention schools
RxNorm normalized name: cetylpyridinium chloride Topical Spray [Rocco's Old School]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention schools received staff asthma-training session, advice on asthma policy, an emergency beta2-agonist inhaler with spacer, and whole-class asthma workshops.
Trial: 14553956
Drug: Lisinopril (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (0.07 mg/kg once daily)
Trial: 11061364
Drug: Cilazapril 20
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 20 mg/day
Trial: 8931406
Drug: Prior antibiotics
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior antibiotics
Trial: 2439798
Drug: bisoprolol (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bisoprolol (0.07 mg/kg i.v.)
Trial: 2439798
Drug: metoprolol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoprolol (0.2 mg/kg i.v.)
Trial: 2439798
Drug: acebutolol (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acebutolol (0.8 mg/kg i.v.)
Trial: 2439798
Drug: penbutolol (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: penbutolol (0.04 mg/kg i.v.)
Trial: 2439798
Drug: propranolol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol (0.2 mg/kg i.v.)
Trial: 20597141
Drug: Donepezil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (10 mg/day over 24 weeks)
Trial: 16002019
Drug: Single-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose oral ciprofloxacin (500 mg)
Trial: 16002019
Drug: Single-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose intravenous cefazolin (1g)
Trial: 7805081
Drug: Less intense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Less intense anticoagulant regimens with or without concomitant antiplatelet therapy
Trial: 7805081
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants for tissue valves
Trial: 7805081
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants for mechanical valves
Trial: 12177586
Drug: Agomelatine 25
RxNorm normalized name: Agomelatine 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 25 mg once a day
Trial: 12177586
Drug: Agomelatine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine (1 mg, 5 mg, 25 mg)
Trial: 7610473
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of 50 gr protein for 2000 kcal
Trial: 2231217
Drug: Cisapride (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (7.5 to 10 mg) three times daily for 6 months
Trial: 2231217
Drug: Placebo three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo three times daily for 6 months
Trial: 302373
Drug: Methylprednisolone (MP)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (MP) 2 Gm administered 1/2 hour prior to cardiopulmonary bypass (CPB)
Trial: 302373
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no MP treatment)
Trial: 31090968
Drug: Weekly alerts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly alerts to providers
Trial: 31090968
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (financial incentives and weekly alerts)
Trial: 15063428
Drug: Atorvastatin (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (n = 28)
Trial: 8179230
Drug: Fluticasone propionate,
RxNorm normalized name: fluticasone propionate, micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate, 200 micrograms, twice daily
Trial: 8179230
Drug: Fluticasone propionate,
RxNorm normalized name: fluticasone propionate, micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone propionate, 200 micrograms, once daily
Trial: 20503397
Drug: Supplement containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement containing isoflavones and curcumin
Trial: 16226371
Drug: Methylphenidate 0.3mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.3mg/kg per dose PO BID from the second day of admission until discharge
Trial: 10389911
Drug: HER-2/neu peptide-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HER-2/neu peptide-based vaccine
Trial: 8916623
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for anxiety disorders
Trial: 1876247
Drug: Intrathecally administered
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecally administered morphine 0.125 mg
Trial: 1876247
Drug: Intrathecally administered
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecally administered morphine 0.25 mg
Trial: 1876247
Drug: Intrathecally administered
RxNorm normalized name: beractant
DrugBank: Beractant (DB06761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecally administered morphine 0.5 mg
Trial: 1876247
Drug: Systemic narcotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic narcotic administration
Trial: 6819276
Drug: 14 MeV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 MeV d + T fast neutrons; Dosage: 18 to more than 22 Gy; Treatment method: two parallel opposed ports
Trial: 6819276
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose neutrons; Treatment method: randomized in a three arm trial
Trial: 31594635
Drug: Relugolix (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relugolix (40 mg once daily for 12 weeks)
Trial: 24122836
Drug: Amoxicillin 750
RxNorm normalized name: amoxicillin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 750 mg bid
Trial: 24122836
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg tid
Trial: 24122836
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg qid
Trial: 24122836
Drug: Amoxicillin 750
RxNorm normalized name: amoxicillin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 750 mg bid with metronidazole 250 mg bid
Trial: 24122836
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg tid with metronidazole 250 mg bid
Trial: 24122836
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg qid with metronidazole 250 mg bid
Trial: 11843929
Drug: Topical oxymetazoline
RxNorm normalized name: oxymetazoline Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical oxymetazoline (decongestion)
Trial: 9542322
Drug: IFN dose
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN dose > or = 30 MU/month
Trial: 3291557
Drug: Propafenone, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone, 150 mg four times daily
Trial: 3291557
Drug: Disopyramide, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disopyramide, 100 mg four times daily
Trial: 330483
Drug: amoxycillin 250
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amoxycillin 250 mg and pivmecillinam 200 mg
Trial: 330483
Drug: amoxycillin 500
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amoxycillin 500 mg
Trial: 330483
Drug: amoxycillin 500
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: amoxycillin 500 mg and pivmecillinam 400 mg
Trial: 31547438
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (sodium restriction + hydrochlorothiazide)
Trial: 28145162
Drug: Corticosteroids plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids plus standard treatment (TMP/SMX)
Trial: 28145162
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus placebo
Trial: 24266960
Drug: Intensive lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive lipid lowering (target LDL-c < 1.4 mmol/l)
Trial: 24266960
Drug: Guideline lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline lipid lowering (target LDL-c < 3 mmol/l)
Trial: 24266960
Drug: Intensive blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive blood pressure lowering therapy for hemorrhagic stroke
Trial: 24266960
Drug: Intensive blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive blood pressure lowering therapy for ischemic stroke
Trial: 24266960
Drug: Maintaining differences
RxNorm normalized name: phenazopyridine
DrugBank: Phenazopyridine (DB01438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maintaining differences in LDL-c (> 1 mmol/l)
Trial: 15197210
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) supplement 1.09 g administered bid
Trial: 15197210
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (MA) liquid suspension 600 mg/d
Trial: 15197210
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EPA and MA
Trial: 8143399
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg felodipine ER
Trial: 8143399
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg felodipine ER
Trial: 8143399
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg felodipine ER
Trial: 3278186
Drug: Interferon alpha-n1
RxNorm normalized name: Interferon alpha-n1 (INS)
DrugBank: Interferon alfa-n1 (DB00011)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha-n1 (Wellferon) at a dose of 5 MU/m2 daily for 28 days and three times weekly for 5 months
Trial: 28526381
Drug: L-GSH supplementation
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-GSH supplementation
Trial: 1503442
Drug: Imipenem (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem (500 mg four times daily)
Trial: 1503442
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (gentamicin 80 mg every 8 h plus either cefuroxime 1,500 mg every 8 h or cephalothin 1,000 mg every 4 h)
Trial: 26241253
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg intramuscular injection
Trial: 26241253
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg intramuscular injection (Nulliparous participants)
Trial: 26241253
Drug: Placebo saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo saline injection (Nulliparous participants)
Trial: 23764734
Drug: GLP-1 (7-36)
RxNorm normalized name: GLP-1 (7-36) amide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 (7-36) treatment in lean humans
Trial: 23764734
Drug: GLP-1 (7-36)
RxNorm normalized name: GLP-1 (7-36) amide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 (7-36) treatment in obese humans
Trial: 23764734
Drug: GLP-1 (7-36)
RxNorm normalized name: GLP-1 (7-36) amide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 (7-36) treatment in lean swine
Trial: 23764734
Drug: GLP-1 (7-36)
RxNorm normalized name: GLP-1 (7-36) amide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 (7-36) treatment in obese swine
Trial: 20587585
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily insulin injections (injection therapy)
Trial: 12532161
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg tid plus hypocaloric diet for the first year and weight maintenance diet in year two
Trial: 6449753
Drug: ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ipratropium bromide 1 mg
Trial: 6449753
Drug: ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ipratropium bromide 0.1 mg
Trial: 30077419
Drug: Intralesional steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional steroid (ILS) injection
Trial: 28832876
Drug: Cigarettes with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarettes with 0.4 mg/g nicotine content
Trial: 28832876
Drug: All nicotine
RxNorm normalized name: NICOTINE 4 mg ORAL LOZENGE [Rexall Nicotine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All nicotine doses
Trial: 28832876
Drug: Higher nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher nicotine doses
Trial: 26343274
Drug: Tight-control treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tight-control treatment strategy using the handscan (TCHS)
Trial: 23582109
Drug: Baclofen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (10 mg twice daily, increasing to 25 mg over three weeks)